Zhejiang Chemsyn Pharm CoBJSE:920656 36 ROA % is 10.81% as of Mar. 2026, which is 54% below its 10-year median of 23.72. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks better than 88.89% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Zhejiang Chemsyn Pharm Co's annualizedNet Income for the quarter that ended in Mar. 2026 was ¥80.4 Mil.
Zhejiang Chemsyn Pharm Co's average Total Assets over the quarter that ended in Mar. 2026 was ¥743.6 Mil. Therefore, Zhejiang Chemsyn Pharm Co's annualized ROA % for the quarter that ended in Mar. 2026 was 10.81%.
The historical rank and industry rank for Zhejiang Chemsyn Pharm Co's ROA % or its related term are showing as below:
BJSE:920656'
s ROA % Range Over the Past 10 Years
Min: 4.93 Med: 23.72 Max: 56.83
Current: 10.63
During the past 12 years, Zhejiang Chemsyn Pharm Co's highest ROA % was 56.83%. The lowest was 4.93%. And the median was 23.72%.
BJSE:920656's ROA % is ranked better than 88.89% of 18
companies
in the Healthcare Plans industry
Industry Median: 2.035
vs BJSE:920656: 10.63
Zhejiang Chemsyn Pharm Co (BJSE:920656) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co ROA % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's ROA % distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a ROA % of 10.81% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is 54% below median its historical median of 23.72. Over the past decade, Zhejiang Chemsyn Pharm Co's ROA % has ranged from 4.93 to 56.83. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #2 out of 18 companies in the Healthcare Plans industry, placing it in the top 11.1%.
Is Zhejiang Chemsyn Pharm Co's ROA % too high?
Zhejiang Chemsyn Pharm Co's current ROA % of 10.81% is 54% below median its 10-year median of 23.72. Over the past 10 years, this metric has ranged from a low of 4.93 to a high of 56.83. The Healthcare Plans industry median ROA % is 2.04. Zhejiang Chemsyn Pharm Co's value of 10.81% is 431.2% above this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #2 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's ROA % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #2 out of 18 companies for ROA %. This places Zhejiang Chemsyn Pharm Co in the top 11% of its industry — outperforming the majority of peers. The industry median ROA % is 2.04. Zhejiang Chemsyn Pharm Co's value of 10.81% is 431.2% above this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own ROA % has ranged from 4.93 to 56.83 over the past decade. While the company's 10-year median is 23.72 vs. the industry median of 2.04, Zhejiang Chemsyn Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Plans company?
The median ROA % among Healthcare Plans companies is 2.04, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current ROA % of 10.81% is 431.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median ROA % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current ROA % is 10.81%, which is 54% below median its own 10-year median of 23.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current ROA % of 10.81%. The current ROA % is 10.81%, which is 54% below median its 10-year median of 23.72 and 431.2% above the Healthcare Plans industry median of 2.04. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current ROA % is 10.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
